Renqing Zhao · 2024 · Journal of Neuroinflammation
Paper
Abstract Neuroinflammation is a pathological hallmark of Alzheimer’s disease (AD), characterized by the stimulation of resident immune cells of the brain and the penetration of peripheral immune cells. These inflammatory processes facilitate the deposition of amyloid-beta (Aβ) plaques and the abnormal hyperphosphorylation of tau protein. Managing neuroinflammation to restore immune homeostasis and decrease neuronal damage is a therapeutic approach for AD. One way to achieve this is through exercise, which can improve brain function and protect against neuroinflammation, oxidative stress, and synaptic dysfunction in AD models. The neuroprotective impact of exercise is regulated by various molecular factors that can be activated in the same way as exercise by the administration of their mimetics. Recent evidence has proven some exercise mimetics effective in alleviating neuroinflammation and AD, and, additionally, they are a helpful alternative option for patients who are unable to perform regular physical exercise to manage neurodegenerative disorders. This review focuses on the current state of knowledge on exercise mimetics, including their efficacy, regulatory mechanisms, progress, challenges, limitations, and future guidance for their application in AD therapy.
Analysis
This review explores exercise mimetics as a therapeutic strategy to combat neuroinflammation and Alzheimer's disease (AD) by mimicking the beneficial effects of exercise for patients unable to engage in physical activity.
Discovery
John Chulhoon Park; Leechung Chang; Ho‐Keun Kwon; Sin‐Hyeog Im
Kenneth J. O’Riordan; Gerard M. Moloney; Lily Keane; Gerard Clarke; John F. Cryan
Echo Yongqi Luo; Rio Ryohichi Sugimura
Anbiao Wu; Jiyan Zhang
Weifeng Zhang; Dan Xiao; Qinwen Mao; Haibin Xia
Eduardo Candelario‐Jalil; Rick M. Dijkhuizen; Tim Magnus
Source record